Statement Of Cash Flows [Abstract]

PureTech Health plc - Filing #1607985

Concept 2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
As at
2019-12-31
As at
2018-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)
2,151,000 USD
60,558,000 USD
62,709,000 USD
60,558,000 USD
5,985,000 USD
4,568,000 USD
1,417,000 USD
5,985,000 USD
421,144,000 USD
421,144,000 USD
366,065,000 USD
55,079,000 USD
Adjustments to reconcile profit (loss) [abstract]
Adjustments for income tax expense
3,756,000 USD
14,402,000 USD
112,077,000 USD
Adjustments for finance costs
5,050,000 USD
6,114,000 USD
46,229,000 USD
Adjustments for increase (decrease) in trade accounts payable
8,338,000 USD
605,000 USD
11,166,000 USD
Adjustments for increase (decrease) in other operating payables
USD
7,000 USD
3,002,000 USD
Adjustments for depreciation and amortisation expense
7,287,000 USD
6,645,000 USD
6,665,000 USD
Adjustments for share-based payments
13,950,000 USD
10,718,000 USD
14,468,000 USD
Adjustments for fair value losses (gains)
179,316,000 USD
232,674,000 USD
37,863,000 USD
Adjustments for losses (gains) on disposal of non-current assets
20,925,000 USD
54,976,000 USD
USD
Interest paid, classified as operating activities
3,382,000 USD
2,651,000 USD
2,495,000 USD
Interest received, classified as operating activities
214,000 USD
1,155,000 USD
3,648,000 USD
Income taxes paid (refund), classified as operating activities
27,766,000 USD
20,737,000 USD
USD
Other inflows (outflows) of cash, classified as operating activities
103,000 USD
USD
USD
Cash flows from (used in) operating activities
158,274,000 USD
131,827,000 USD
98,156,000 USD
Cash flows from (used in) investing activities [abstract]
Cash flows from losing control of subsidiaries or other businesses, classified as investing activities
USD
USD
16,036,000 USD
Other cash receipts from sales of equity or debt instruments of other entities, classified as investing activities
218,125,000 USD
350,586,000 USD
9,294,000 USD
Other cash payments to acquire equity or debt instruments of other entities, classified as investing activities
500,000 USD
1,150,000 USD
1,556,000 USD
Proceeds from sales of property, plant and equipment, classified as investing activities
30,000 USD
USD
USD
Purchase of property, plant and equipment, classified as investing activities
5,571,000 USD
5,170,000 USD
12,138,000 USD
Purchase of intangible assets, classified as investing activities
90,000 USD
254,000 USD
400,000 USD
Cash flows from (used in) investing activities
197,375,000 USD
364,478,000 USD
63,659,000 USD
Cash flows from (used in) financing activities [abstract]
Payments from changes in ownership interests in subsidiaries that do not result in loss of control
806,000 USD
USD
USD
Payments of lease liabilities, classified as financing activities
3,375,000 USD
2,908,000 USD
1,678,000 USD
Other inflows (outflows) of cash, classified as financing activities
5,000 USD
USD
USD
Cash flows from (used in) financing activities
22,727,000 USD
38,869,000 USD
49,910,000 USD
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
USD
USD
104,000 USD
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
61,827,000 USD
271,520,000 USD
15,309,000 USD
Cash and cash equivalents
465,708,000 USD
403,881,000 USD
132,360,000 USD
117,051,000 USD

Talk to a Data Expert

Have a question? We'll get back to you promptly.